HAUSMAN DIANA 4
4 · Immuneering Corp · Filed Jan 18, 2022
Insider Transaction Report
Form 4
Immuneering CorpIMRX
HAUSMAN DIANA
Director
Transactions
- Award
Stock Option
2022-01-14$13.00/sh+25,200$327,600→ 25,200 totalExercise: $13.00Exp: 2032-01-13→ Class A Common Stock (25,200 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a three year period commencing on February 14, 2022, and will be fully vested and exercisable on January 14, 2025.